drugset / Trial / NCT00515424

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

NCT00515424 ↗

Phase 1 Completed 90 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the tolerability and safety of RKI983 ophthalmic solution and explore the effect of the compound on intraocular pressure in subjects with ocular hypertension.

Timeline

Start
2007-07
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject RKI983 Unknown — Other